Deprescribing Steps: Shared Decision-Making with Patients

Added:

Clinician-Led Deprescribing and Clinical Paternalism

While shared decision-making is highly valued, some clinical frameworks and ethicists advocate for clinician-led, or even paternalistic, deprescribing under certain circumstances. This counter-perspective argues that relying heavily on patient consensus can be counterproductive due to cognitive barriers, such as the 'endowment effect' (where patients overvalue medications they have taken for years) or fear of withdrawal. In cases involving cognitive decline, advanced dementia, or low health literacy, active shared decision-making is often impractical or impossible. Critics argue that prioritizing patient preferences over objective clinical risk assessments can lead to prolonged exposure to potentially inappropriate medications. In these situations, an evidence-based, clinician-driven approach—where the physician takes primary responsibility for stopping harmful medications based on clinical guidelines—is proposed as safer, faster, and more effective at preventing adverse drug events.

The concept of polypharmacy and the clinical risks associated with over-medication, particularly in geriatric and multi-morbid populations.
Basic principles of pharmacology, including medication side effects, drug-drug interactions, and the definition of adverse drug events (ADEs).
The foundational definition and purpose of 'deprescribing' as a planned and supervised process of medication withdrawal or dose reduction.
The core tenets of patient-centered care and the general framework of Shared Decision-Making (SDM) in clinical practice.
Application of clinical screening tools and criteria, such as the Beers Criteria or STOPP/START criteria, to systematically identify medications suitable for discontinuation.
Designing evidence-based tapering schedules and clinical monitoring plans to safely manage potential withdrawal symptoms or the return of underlying conditions.
Advanced communication techniques to address patient barriers, health beliefs, and anxieties regarding the cessation of long-term maintenance medications.
Implementing interprofessional workflows that engage pharmacists, nurses, and family caregivers in the coordinated deprescribing process.
3.4K views19likes55:28@deprescribingOriginal Release: 2018-06-27

Deprescribing is the planned and supervised process of reducing or stopping medications that may no longer be beneficial or may be causing harm, and shared decision-making is essential because it addresses the gap between clinical evidence suggesting medication reduction benefits and patient behavior patterns that often resist such changes; effective deprescribing requires clinicians to create awareness of options, discuss benefits and harms transparently, explore patient preferences, and implement decisions through staged approaches like 'pause and monitor,' while recognizing that cognitive biases, communication barriers, and patient fears must be addressed to achieve successful medication reduction.